- Home
- SJT vs STXS Comparison
SJT vs STXS Comparison
Compare SJT & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SJT
- STXS
- Stock Information
- Founded
- SJT 1980
- STXS 1990
- Country
- SJT United States
- STXS United States
- Employees
- SJT N/A
- STXS N/A
- Industry
- SJT Oil & Gas Production
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SJT Energy
- STXS Health Care
- Exchange
- SJT Nasdaq
- STXS Nasdaq
- Market Cap
- SJT 269.4M
- STXS 261.1M
- IPO Year
- SJT N/A
- STXS 2004
- Fundamental
- Price
- SJT $5.78
- STXS $2.85
- Analyst Decision
- SJT
- STXS
- Analyst Count
- SJT 0
- STXS 0
- Target Price
- SJT N/A
- STXS N/A
- AVG Volume (30 Days)
- SJT 200.0K
- STXS 406.8K
- Earning Date
- SJT 11-13-2025
- STXS 11-10-2025
- Dividend Yield
- SJT N/A
- STXS N/A
- EPS Growth
- SJT N/A
- STXS N/A
- EPS
- SJT N/A
- STXS N/A
- Revenue
- SJT $42,635.00
- STXS $31,806,000.00
- Revenue This Year
- SJT N/A
- STXS $30.92
- Revenue Next Year
- SJT N/A
- STXS $43.27
- P/E Ratio
- SJT N/A
- STXS N/A
- Revenue Growth
- SJT N/A
- STXS 33.94
- 52 Week Low
- SJT $3.27
- STXS $1.54
- 52 Week High
- SJT $7.22
- STXS $3.05
- Technical
- Relative Strength Index (RSI)
- SJT 47.52
- STXS 56.73
- Support Level
- SJT $5.73
- STXS $2.81
- Resistance Level
- SJT $5.91
- STXS $2.92
- Average True Range (ATR)
- SJT 0.13
- STXS 0.11
- MACD
- SJT 0.01
- STXS -0.01
- Stochastic Oscillator
- SJT 26.47
- STXS 62.07
About SJT San Juan Basin Royalty Trust
San Juan Basin Royalty Trust is an energy sector royalty trust in the United States. It owns approximately 75% net profit interest in a large number of natural gas properties in the San Juan Basin of New Mexico. About 98% of the royalties San Juan collects come from natural gas, with the balance coming from oil.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.